Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|January 13, 2012
[Systemic therapy for advanced endometrial cancer]Youssef Tazi, Patricia Pautier, Catherine Lhommé
Bulletin Du Cancer|December 15, 2012
[The molecular biology of epithelial ovarian cancer]Alexandra Leary, Patricia Pautier, Youssef Tazi, et al.
Gynecologic Oncology|November 14, 2013
Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implantsAlexandra Leary, Marie Christina Petrella, Patricia Pautier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2015
Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experienceJulien Hadoux, Annie Rey, Pierre Duvillard, et al.
Bulletin Du Cancer|September 6, 2013
[Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment]Julien Hadoux, Philippe Morice, Catherine Lhommé, et al.
The Oncologist|May 24, 2021
COVID-19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS-CoV-2 Cluster During the First Wave of the COVID-19 PandemicSophie Martin, Charlotte Kaeuffer, Pierre Leyendecker, et al.
Oncology Letters|March 22, 2016
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort studyFrédéric Selle, George Emile, Patricia Pautier, et al.
European Urology|November 18, 2021
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC TrialGiulia Baciarello, Remy Delva, Gwenaelle Gravis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2022
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trialAntonio González-Martín, Christophe Desauw, Florian Heitz, et al.
Cancers|July 24, 2021
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study GroupCandice Hober, Lisa Fredeau, Anne Pham-Ledard, et al.
Pageof 1